Varenicline, the clinically effective smoking cessation agent, restores probabilistic response reversal performance during withdrawal from nicotine. (2017)
Attributed to:
Newcastle University Confidence in Concept 2014
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/adb.12423
PubMed Identifier: 27440124
Publication URI: http://europepmc.org/abstract/MED/27440124
Type: Journal Article/Review
Volume: 22
Parent Publication: Addiction biology
Issue: 5
ISSN: 1355-6215